Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Citations 0
Special Feature
March 01, 2005

Image of the Month—Diagnosis

Author Affiliations

Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2005

Arch Surg. 2005;140(3):312. doi:10.1001/archsurg.140.3.312
Answer: Papillary Low-Grade Neuroendocrine Tumor of the Pancreas With Pancreatic Duct Dilation

Figure 1. Axial magnetic resonance image of the abdomen demonstrating large pancreatic ductal dilation without obvious mass.

Figure 2. Intraoperative photograph demonstrating an enlarged main pancreatic duct (black arrows) and enlarged peripheral pancreatic ducts (white arrows).

Prominent pancreatic duct dilation with a mass lesion within the head of the pancreas has been found to represent a primary adenocarcinoma of the pancreas in most patients. These patients are also found to have concomitant biliary dilation. Isolated significant (>2-cm) pancreatic ductal dilation has been demonstrated to occur more commonly in mucin-producing lesions of the pancreas and primarily in intraductal papillary mucinous tumors of the pancreas.1

Neuroendocrine lesions of the pancreas represent 0.5% of all pancreatic tumors.2 Approximately one third of neuroendocrine tumors are hormonally inactive and account for about 20% of all endocrine tumors of the pancreas.3 Histochemically, they are identified as insulin (50% of cases), pancreatic polypeptide (40%), glucagon (30%), and somatostatin (13%) cells. Nonfunctioning pancreatic tumors are usually unifocal, except when associated with multiple endocrine neoplasia type 1 syndrome.4 These lesions usually occur during the fourth or fifth decade of life, with an even sex distribution.5

Because these tumors remain clinically silent during their growth, they may attain great size without causing apparent clinical findings and commonly present in an advanced stage. Other forms of nonfunctioning neuroendocrine tumors, when originating in critical locations, can be found with elevated liver function test results or, as in this case, as a dilated pancreatic duct.

Patients who present with significant pancreatic ductal dilation should be examined to rule out proximal mass lesions. Most of these patients will ultimately undergo pancreaticoduodenectomy, which establishes the final diagnosis.

Box Section Ref ID


The Editor welcomes contributions to the “Image of the Month.” Send manuscripts to Archives of Surgery, Johns Hopkins Medical Institutions, 720 Rutland Ave, Ross 759, Baltimore, MD 21205; (443) 287-0026; e-mail: Articles and photographs accepted will bear the contributor’s name. Manuscript criteria and information are per the “Instructions for Authors” for Archives of Surgery. No abstract is needed, and the manuscript should be no more than 3 typewritten pages. There should be a brief introduction, 1 multiple-choice question with 4 possible answers, and the main text. No more than 2 photographs should be submitted. There is no charge for reproduction and printing of color illustrations.

Back to top
Article Information

Correspondence: Robert C. G. Martin II, MD, Department of Surgery, University of Louisville, Norton Healthcare Pavilion, Room 312, 315 E Broadway, Louisville, KY 40202 (

Accepted for Publication: April 28, 2003.

Sohn  TAYeo  CJCameron  JLIacobuzio-Donahue  CAHruban  RHLillemoe  KD Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 2001;234313- 321
Phan  GQYeo  CJHruban  RHLillemoe  KDPitt  HACameron  JL Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 1998;2472- 482
Hochwald  SNZee  SConlon  KC  et al.  Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002;202633- 2642
Norton  JAAlexander  HRFraker  DLVenzon  DJGibril  FJensen  RT Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg 2001;234495- 505
Eriksson  BOberg  K Pipomas and nonfunctioning endocrine pancreatic tumors: clinical presentation, diagnosis, and advances in management. Mignon MJensen RTeds.Endocrine Tumors of the Pancreas Recent Advances in Research and Management. Basel, Switzerland: S Karger AG1995;208- 222